http://ec.europa.eu//research/index.cfm?pg=whatsnew en Thu, 23 May 2013 14:30:10 GMT http://ec.europa.eu/research/index.cfm?pg=rss For more RSS news feeds click the link above. Thu, 23 May 2013 14:30:10 GMT http://ec.europa.eu/research/index.cfm?pg=rss http://ec.europa.eu/research/index.cfm?pg=world-cancer-day-2013 Fri, 01 Feb 2013 00:00:00 GMT tag:ch,2013-02-01:/index.cfm?pg=world-cancer-day-2013 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/star/index_en.cfm?p=ss-canceromics&calledby=infocentre&item=Infocentre&artid=28759 Advances in microarray or lab-on-a-chip technologies have significantly improved our ability to study human cells and tissues. However, in order to develop novel therapies to combat such diseases as cancer, understanding the underlying molecular mechanisms is required and this is only made possible by developing new technologies. ]]> Wed, 19 Dec 2012 00:00:00 GMT tag:ch,2012-12-19:/infocentre/article_en.cfm?id=/research/star/index_en.cfm?p=ss-canceromics&calledby=infocentre&item=Infocentre&artid=28759 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_11_06_en.html&item=Infocentre&artid=27953 A new study conducted by European researchers in Denmark suggests that regular use of pain relief medications such as aspirin, can lead to a decreased risk of serous ovarian cancer in women. This is important news because despite significant progress in the field of gynaecological cancer treatment during recent decades, the prognosis has remained poor, and many have stressed that preventive strategies are urgently needed.]]> Tue, 06 Nov 2012 00:00:00 GMT tag:ch,2012-11-06:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_11_06_en.html&item=Infocentre&artid=27953 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_06_01_en.html&item=Infocentre&artid=25013 Life expectancy for HIV patients treated with antiretroviral drugs, now considered common course in treating the virus, can expect to live considerably longer lives, new research from the United Kingdom shows. This study was funded in part by the EUROCOORD ('European network of HIV/AIDS cohort studies to coordinate at European and international level clinical research on HIV/AIDS') project, which is backed with EUR 12 million under the Health Theme of the FP7. EUROCOORD brings together a number of other networks, all of which have played a central role in developing our understanding, progression and treatment of HIV.]]> Fri, 01 Jun 2012 00:00:00 GMT tag:ch,2012-06-01:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_06_01_en.html&item=Infocentre&artid=25013 http://ec.europa.eu/research/horizon2020/index_en.cfm?pg=testimonials&video=none Fri, 09 Mar 2012 00:00:00 GMT tag:ch,2012-03-09:/horizon2020/index_en.cfm?pg=testimonials&video=none http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_05_en.html&item=Infocentre&artid=24113 An international team of researchers led by the University of Leicester in the United Kingdom has identified a genetic link for coronary artery disease (also called coronary heart disease). The results of the study, presented in the journal The Lancet, demonstrate how a father passes on to his son a common heart disease that kills thousands each year. The study was supported in part by a grant under the FP6.]]> Mon, 05 Mar 2012 00:00:00 GMT tag:ch,2012-03-05:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_05_en.html&item=Infocentre&artid=24113 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_02_en.html&item=Infocentre&artid=24093 Autism spectrum disorders (ASDs) have a complex inheritance pattern. Despite researchers having identified rare variants in synaptic proteins in patients with ASD, little work has been carried out to determine the effect at the synapse and their interactions with other genetic variations ... until now. A European team of researchers has confirmed that synaptic mutations heightens the risk of ASD. The study, presented in the journal PLoS Genetics, was funded in part by the EUHFAUTISM ('European high-functioning autism network: translational research in a phenotypically well characterised sample') project, a Neuron-ERA-NET funded under the EU's Seventh Framework Programme (FP7) to the tune of almost EUR 370 000.]]> Fri, 02 Mar 2012 00:00:00 GMT tag:ch,2012-03-02:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_03_02_en.html&item=Infocentre&artid=24093 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_02_24_en.html&item=Infocentre&artid=24033 An international team of scientists has discovered a key molecule that helps the malaria parasite evade the human body's immune system. Partially funded by the EU-backed EVIMALAR ('Towards the establishment of a permanent European virtual institute dedicated to malaria research') project and presented in the journal Cell Host & Microbe, the findings of this study could provide fresh insight into how the parasite that triggers disease can dodge the defences built by the immune system. EVIMALAR, meanwhile, is funded under the Health Theme of the FP7 to the tune of EUR 12 million.]]> Fri, 24 Feb 2012 00:00:00 GMT tag:ch,2012-02-24:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_02_24_en.html&item=Infocentre&artid=24033 http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_02_21_en.html&item=Infocentre&artid=23973 British and German researchers led by the University of Southampton in the United Kingdom have found that vitamins could help fight malaria. The findings of the study, presented in the journal Structure, could encourage the development of more effective drugs to fight this disease. This disorder affects more than 250 million people each year, and kills over 650 000 people. The study was funded in part by a grant under the FP6. ]]> Tue, 21 Feb 2012 00:00:00 GMT tag:ch,2012-02-21:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_02_21_en.html&item=Infocentre&artid=23973 http://ec.europa.eu/research/horizon2020/index_en.cfm?pg=press#other Tue, 31 Jan 2012 00:00:00 GMT tag:ch,2012-01-31:/horizon2020/index_en.cfm?pg=press/other http://ec.europa.eu/research/infocentre/article_en.cfm?id=/research/headlines/news/article_12_01_25_en.html&item=Infocentre&artid=23713 Scientists in Finland have discovered how a biochemical signature can potentially predict progression to Alzheimer's disease. The study is funded in part by the PREDICTAD ('From patient data to personalised healthcare in Alzheimer's disease') project, which received almost EUR 2.9 million under the 'Information and communication technologies' Theme of the FP7. Results suggest that this neurological disorder is preceded by a molecular signature indicative of hypoxia and an upregulated pentose phosphate pathway. The study, published in the journal Translational Psychiatry, could lead to the development of methods for early disease detection.]]> Wed, 25 Jan 2012 00:00:00 GMT tag:ch,2012-01-25:/infocentre/article_en.cfm?id=/research/headlines/news/article_12_01_25_en.html&item=Infocentre&artid=23713